Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction

Yulia Belenkova,1,2 Viktoria Karetnikova,1,2 Aleksey Diachenko,2 Olga Gruzdeva,1 Olga Blagoveshchenskaya,3 Tatiana Molodtsova,3 Evgenya Uchasova,1 Olga Barbarash1,2 1Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, Siberian Branch of the Russian A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Belenkova Y, Karetnikova V, Diachenko A, Gruzdeva O, Blagoveshchenskaya O, Molodtsova T, Uchasova E, Barbarash O
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://doaj.org/article/750a45648d5d49c5af47286cd2979d99
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:750a45648d5d49c5af47286cd2979d99
record_format dspace
spelling oai:doaj.org-article:750a45648d5d49c5af47286cd2979d992021-12-02T01:49:50ZAssociation of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction1178-7031https://doaj.org/article/750a45648d5d49c5af47286cd2979d992015-05-01T00:00:00Zhttp://www.dovepress.com/association-of-inflammatory-markers-and-poor-outcome-in-diabetic-patie-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Yulia Belenkova,1,2 Viktoria Karetnikova,1,2 Aleksey Diachenko,2 Olga Gruzdeva,1 Olga Blagoveshchenskaya,3 Tatiana Molodtsova,3 Evgenya Uchasova,1 Olga Barbarash1,2 1Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, Siberian Branch of the Russian Academy of Medical Sciences, 2State Budgetary Educational Institution of Higher Professional Education Kemerovo State Medical Academy of the Russian Ministry of Health, 3State Budgetary Healthcare Institution Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation Objective: Carbohydrate metabolism disorders (CMD) significantly impact the development and progression of all forms of ischemic heart disease, and inflammation is regarded as a general pathogenetic link between CMD and ischemic heart disease. Methods: A total of 601 patients with ST segment elevation myocardial infarction (MI) (STEMI), admitted within 24 hours from the onset of symptoms during 1 year, were included in this registry study. The blood levels of inflammation markers were measured at days 10–14 with further follow up at 1 year. Results: The analysis of acute-phase percutaneous coronary intervention impact on the 1-year outcomes showed that endovascular revascularization significantly improved the 1-year prognosis of STEMI patients both with and without CMD. The analysis of inflammation markers showed significantly higher levels of interleukin (IL)-6 and sCD40L in MI patients with diabetes mellitus, and impaired glucose tolerance. Additionally, the patients with impaired glucose tolerance had significantly higher IL-12 levels. In the diabetic MI patients, the odds ratio of a poor 1-year outcome was high for patients with a high Killip classification of acute heart failure upon admission. Conclusion: Persistent inflammation in STEMI patients with CMD undergoing percutaneous coronary intervention might be responsible for vascular complications within 1 year after MI. Comorbid diabetes mellitus or impaired glucose tolerance can amplify the significance of the inflammatory response for the development of adverse 1-year outcomes. Keywords: carbohydrate metabolism disorders, inflammation percutaneous coronary intervention Belenkova YKaretnikova VDiachenko AGruzdeva OBlagoveshchenskaya OMolodtsova TUchasova EBarbarash ODove Medical PressarticlePathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol 2015, Iss default, Pp 107-116 (2015)
institution DOAJ
collection DOAJ
language EN
topic Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Belenkova Y
Karetnikova V
Diachenko A
Gruzdeva O
Blagoveshchenskaya O
Molodtsova T
Uchasova E
Barbarash O
Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
description Yulia Belenkova,1,2 Viktoria Karetnikova,1,2 Aleksey Diachenko,2 Olga Gruzdeva,1 Olga Blagoveshchenskaya,3 Tatiana Molodtsova,3 Evgenya Uchasova,1 Olga Barbarash1,2 1Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, Siberian Branch of the Russian Academy of Medical Sciences, 2State Budgetary Educational Institution of Higher Professional Education Kemerovo State Medical Academy of the Russian Ministry of Health, 3State Budgetary Healthcare Institution Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation Objective: Carbohydrate metabolism disorders (CMD) significantly impact the development and progression of all forms of ischemic heart disease, and inflammation is regarded as a general pathogenetic link between CMD and ischemic heart disease. Methods: A total of 601 patients with ST segment elevation myocardial infarction (MI) (STEMI), admitted within 24 hours from the onset of symptoms during 1 year, were included in this registry study. The blood levels of inflammation markers were measured at days 10–14 with further follow up at 1 year. Results: The analysis of acute-phase percutaneous coronary intervention impact on the 1-year outcomes showed that endovascular revascularization significantly improved the 1-year prognosis of STEMI patients both with and without CMD. The analysis of inflammation markers showed significantly higher levels of interleukin (IL)-6 and sCD40L in MI patients with diabetes mellitus, and impaired glucose tolerance. Additionally, the patients with impaired glucose tolerance had significantly higher IL-12 levels. In the diabetic MI patients, the odds ratio of a poor 1-year outcome was high for patients with a high Killip classification of acute heart failure upon admission. Conclusion: Persistent inflammation in STEMI patients with CMD undergoing percutaneous coronary intervention might be responsible for vascular complications within 1 year after MI. Comorbid diabetes mellitus or impaired glucose tolerance can amplify the significance of the inflammatory response for the development of adverse 1-year outcomes. Keywords: carbohydrate metabolism disorders, inflammation percutaneous coronary intervention 
format article
author Belenkova Y
Karetnikova V
Diachenko A
Gruzdeva O
Blagoveshchenskaya O
Molodtsova T
Uchasova E
Barbarash O
author_facet Belenkova Y
Karetnikova V
Diachenko A
Gruzdeva O
Blagoveshchenskaya O
Molodtsova T
Uchasova E
Barbarash O
author_sort Belenkova Y
title Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
title_short Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
title_full Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
title_fullStr Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
title_full_unstemmed Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction
title_sort association of inflammatory markers and poor outcome in diabetic patients presenting with st segment elevation myocardial infarction
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/750a45648d5d49c5af47286cd2979d99
work_keys_str_mv AT belenkovay associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT karetnikovav associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT diachenkoa associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT gruzdevao associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT blagoveshchenskayao associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT molodtsovat associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT uchasovae associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
AT barbarasho associationofinflammatorymarkersandpooroutcomeindiabeticpatientspresentingwithstsegmentelevationmyocardialinfarction
_version_ 1718402846383144960